Immunic Ag
Clinical trials sponsored by Immunic Ag, explained in plain language.
-
New MS drug aims to stop relapses and slow brain damage
Disease control OngoingThis large, late-stage study is testing whether an investigational oral medication called IMU-838 can help control relapsing multiple sclerosis. It will compare the drug to a placebo in about 1,100 adults to see if it reduces relapses, slows disability progression, and is safe to…
Phase: PHASE3 • Sponsor: Immunic AG • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
Major trial tests promising pill to tame MS Flare-Ups
Disease control OngoingThis large, late-stage study is testing whether a daily pill called IMU-838 can better control relapsing multiple sclerosis compared to a placebo. It involves over 1,100 adults with active MS and will measure if the drug delays flare-ups, slows disability progression, and reduces…
Phase: PHASE3 • Sponsor: Immunic AG • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC